Wednesday , December 1 2021

Marijuana researchers turn their eyes on the elderly



[ad_1]

Cassandra Szklarski, Canada Press

Published on Sunday, 2 December 2018 09:38 EST

TORONTO – When Ash Basu suggested a doctor to see a marijuana specialist, the constant back pain associated with a drop in pain aroused curiosity.

At the age of 64, he had not experienced marijuana, fun, or any other experience, but had heard reports of the plant's pain-relieving potential and was eager to avoid opioids.

He was referred to a cannabis clinic and asked the doctor questions. She wasn't satisfied with what she heard.

In a new information session on medical marijuana in Toronto, Basu was among several dozen elderly, saying, "He didn't know much."

"The problem I have is that there is no data about the interactions between all the drugs I take. I have diabetes, I have high blood pressure, I'm in three different allergy medications."

Basu left the clinic with the authority to buy medicinal cannabis oil, but did not buy it two months later. He doesn't think he's coming soon.

Orum I'm really, really scared istem because I don't want to try it because I don't want any reaction and I don't want to fall. It's my biggest concern. ”Said Mississauga, Ont.

There are a lot of questions of interest to marijuana among older people, says the CEO of the Longtime Care Association of Ontario's Candace Chartier.

A major reason for the group to enter a six-month pilot program is to monitor and monitor the effects of medical cannabis use among 500 elderly people in long-term care facilities in Ontario.

Medical marijuana benefits from a range of discomfort for many patients. Chartier says employees and family members are already reporting positive results as anecdotal.

Or It's making an impact, it takes less time to look at the residents,… he says. Incoming caregivers see a difference in the level of pain. “

Li We know you're working on a small scale and that's why we're excited to do it on a larger scale. "

Chartier said the OLTCA would coordinate the program and develop screening tools with cannabis company Canopy Growth, which provides cannabis to nurses, pharmacists, doctors and caregivers.

The results will inform the guidelines that can shape care at facilities across the country: "It will be a clinical support tool for every home in the province to benefit from it," he says.

In the meantime, a similar six-month study was conducted to examine the effect of medical cannabis on sleep, perception of pain, and quality of life in patients over 50 years of age. The cannabis company launched a six-month study, including Tilray.

Philippe Lucas, Tilray's vice president of global patient research and access, said the study would start on Sarnia, Ont.

He expects the patient to be enrolled from 600 to 1000 and is afraid of detailed data on how older people use cannabis and the consequences.

"Any longitudinal monitoring that follows the impact of medical cannabis over time has not been forward-looking work," says Lucas.

Dr. Tilray's Ontario study, including those living in long-term care facilities for seniors specializing in cannabinoid therapy Sarnia-based cannabis specialist Dr. It's led by Blake Pearson.

Pearson estimates that cannabis is not for everyone, but between 60 and 70 percent of patients receiving medical marijuana treatment have seen some sort of improvement.

Al Most often, I can cure a geriatric patient with cannabis oil and potentially reduce the other drugs by two to three, because it's multimodal, P says Pearson.

"So we can sleep pain, worry, three or four different drugs."

Chartier said that reducing drugs not only improves the quality of life for the patient, but also kal quality of workplace for staff kal in long-term care facilities.

Iyor This can shorten the time of drug administration and almost halve it, “he says.

Dr. Canopy's chief health officer. Mark Ware states that medical cannabis research tends to focus on childhood epilepsy and people with moderate chronic pain and spasticity.

. The elderly have not received much interest and there is a good reason to think that they can handle cannabinoids in a different way than a younger person, genç says Montreal-based pain specialist, cannabis in Canada before.

"They may require smaller doses, metabolize drugs more slowly."

He took a big advantage in researching long-term care facilities.

Nö There are very strong monitoring systems for neurocognitive symptoms, sleep and pain scores for drug use. That's why they actually get used to watching the health of their residents. Bu

Basu said he is looking for arm-length research that would assess objective use of medicinal cannabis as an objective for higher levels, and that he found the work on the private sector generally dubious. However, it attaches more importance to the concerns of the elderly.

Or It's all about education, “he says. "I think the industry needs to do more."

[ad_2]
Source link